Buchacz Kate, Armon Carl, Palella Frank J, Novak Richard M, Fuhrer Jack, Tedaldi Ellen, Ward Douglas, Mayer Cynthia, Battalora Linda, Carlson Kimberly, Purinton Stacey, Durham Marcus, Li Jun
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cerner Corporation, Kansas City, Missouri, USA.
Open Forum Infect Dis. 2020 Apr 11;7(5):ofaa123. doi: 10.1093/ofid/ofaa123. eCollection 2020 May.
The clinical epidemiology of treated HIV infection in the United States has dramatically changed in the past 25 years. Few sources of longitudinal data exist for people with HIV (PWH) spanning that period. Cohort data enable investigating new exposure and disease associations and monitoring progress along the HIV care continuum.
We synthesized key published findings and conducted primary data analyses in the HIV Outpatient Study (HOPS), an open cohort of PWH seen at public and private HIV clinics since 1993. We assessed temporal trends in health outcomes (1993-2017) and mortality (1994-2017) for 10 566 HOPS participants.
The HOPS contributed to characterizing new conditions (eg, lipodystrophy), demonstrated reduced mortality with earlier HIV treatment, uncovered associations between select antiretroviral agents and cardiovascular disease, and documented remarkable shifts in morbidity from AIDS opportunistic infections to chronic noncommunicable diseases. The median CD4 cell count of participants increased from 244 cells/mm to 640 cells/mm from 1993 to 2017. Mortality fell from 121 to 16 per 1000 person-years from 1994 to 2017 ( < .001). In 2010, 83.7% of HOPS participants had a most recent HIV viral load <200 copies/mL, compared with 92.2% in 2017.
Since 1993, the HOPS has been detecting emerging issues and challenges in HIV disease management. HOPS data can also be used for monitoring trends in infectious and chronic diseases, immunologic and viral suppression status, retention in care, and survival, thereby informing progress toward the Ending the HIV Epidemic initiative.
在过去25年中,美国接受治疗的艾滋病毒感染的临床流行病学发生了巨大变化。在那段时期,针对艾滋病毒感染者(PWH)的纵向数据来源很少。队列数据有助于调查新的暴露因素与疾病之间的关联,并监测艾滋病毒护理连续过程中的进展情况。
我们综合了已发表的关键研究结果,并在艾滋病毒门诊研究(HOPS)中进行了原始数据分析。HOPS是一个开放队列,自1993年以来,在公立和私立艾滋病毒诊所就诊的PWH都被纳入其中。我们评估了10566名HOPS参与者的健康结局(1993 - 2017年)和死亡率(1994 - 2017年)的时间趋势。
HOPS有助于明确新情况(如脂肪代谢障碍),证明早期艾滋病毒治疗可降低死亡率,发现特定抗逆转录病毒药物与心血管疾病之间的关联,并记录了发病率从艾滋病机会性感染向慢性非传染性疾病的显著转变。参与者的CD4细胞计数中位数从1993年的244个细胞/mm³增加到2017年的640个细胞/mm³。死亡率从1994年的每1000人年121例降至2017年的每1000人年16例(P <.001)。2010年,83.7%的HOPS参与者最近的艾滋病毒病毒载量<200拷贝/mL,而2017年这一比例为92.2%。
自1993年以来,HOPS一直在发现艾滋病毒疾病管理中出现的问题和挑战。HOPS数据还可用于监测传染病和慢性病的趋势、免疫和病毒抑制状态、护理留存率以及生存率,从而为实现“终结艾滋病毒流行”倡议的进展提供信息。